Ncc and Peptidream Announce the First Dosing of 64Cu-Pd-32766 in a Patient With Clear Cell Renal Cell Carcinoma
Ncc和Peptidream宣佈第一次給透明細胞腎癌患者注射64Cu-Pd-32766
Ncc and Peptidream Announce the First Dosing of 64Cu-Pd-32766 in a Patient With Clear Cell Renal Cell Carcinoma
Ncc和Peptidream宣佈第一次給透明細胞腎癌患者注射64Cu-Pd-32766
譯文內容由第三人軟體翻譯。